Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
  1. Home
  2. Publications
  3. Supplementary Table S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Supplementary Table S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial

Authors:
  • AMAlexios Matikas
    Alexios Matikas
  • HJHemming Johansson
    Hemming Johansson
  • PGPer Grybäck
    Per Grybäck
  • JBJudith Bjöhle
    Judith Bjöhle
  • BABalazs Acs
    Balazs Acs
  • CBCeren Boyaci
    Ceren Boyaci
  • TLTobias Lekberg
    Tobias Lekberg
  • HFHanna Fredholm
    Hanna Fredholm
  • EEEllinor Elinder
    Ellinor Elinder
  • SMSara Margolin
    Sara Margolin
  • EIErika Isaksson-Friman
    Erika Isaksson-Friman
  • ABAna Bosch
    Ana Bosch

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707315
Abstract
Supplementary Table S2. Distribution of clinical and pathologic characteristics according to baseline tumor infiltrating lymphocytes (median value as cut-off)
Keywords
  • BREAST CANCER
  • CLINICAL IMAGING
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.